Containment and Recombinant DNA Technology - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Containment

Recombinant DNA Technology

What is the Difference Between Biologics and Biosimilars?

Pharma Packaging Solutions

SEPTEMBER 22, 2023

There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. Biologics are drug products that are manufactured using materials from living sources. What are Biosimilars?

Recombinant DNA Technology

Recombinant DNA Technology Packaging Packaging Pharma Packaging

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

The Pharma Data

JULY 11, 2021

TAKHZYRO is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. Sodium content: This medicinal product contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’ 9. Interactions. No dedicated drug-drug interaction studies have been conducted.

Allergies

Allergies Antibody Recombinant DNA Technology Production

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

What is the Difference Between Biologics and Biosimilars?

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

Webinars

Stay Connected